γ'与总纤维蛋白原水平与静脉血栓栓塞及缺血性卒中的孟德尔随机化研究
本研究采用两样本孟德尔随机化方法,利用全基因组关联研究汇总数据,评估总纤维蛋白原及其γ'亚型对静脉血栓栓塞和缺血性卒中亚型风险的因果效应。基于16个γ'纤维蛋白原和75个总纤维蛋白原遗传工具的主要逆方差加权分析显示,较高的γ'纤维蛋白原和总纤维蛋白原对静脉血栓栓塞风险具有保护作用,较高的γ'纤维蛋白原对心源性栓塞和大动脉卒中风险也有保护作用。敏感性分析结果一致。
要点
- 遗传决定的较高γ'纤维蛋白原水平对静脉血栓栓塞风险具有保护作用。
- 遗传决定的较高总纤维蛋白原水平对静脉血栓栓塞风险具有保护作用。
- 较高γ'纤维蛋白原水平对心源性栓塞和大动脉卒中风险具有保护作用。
核心结论
- 遗传决定的较高γ'纤维蛋白原水平对静脉血栓栓塞和缺血性卒中风险具有保护作用。
研究设计与样本
- 两样本孟德尔随机化研究,使用全基因组关联研究汇总数据。
- γ'纤维蛋白原采用16个遗传工具,总纤维蛋白原采用75个遗传工具。
- 主要分析采用逆方差加权孟德尔随机化方法,辅以MR-Egger、加权中位数MR和加权模式MR等敏感性分析。
主要发现
- 基于16个γ'纤维蛋白原和75个总纤维蛋白原遗传工具的逆方差加权MR估计显示,较高γ'纤维蛋白原和较高总纤维蛋白原对静脉血栓栓塞风险具有保护作用。
- 较高γ'纤维蛋白原水平对心源性栓塞和大动脉卒中风险具有保护作用。
- 效应估计在敏感性分析中保持一致。
临床怎么用
- 研究结果支持遗传决定的γ'纤维蛋白原对静脉血栓栓塞和缺血性卒中风险的影响,但临床转化需进一步研究。
局限性
- 需要进一步研究探索这些效应背后的机制及其临床应用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Fibrinogen is a key component of the coagulation cascade, and variation in its circulating levels may contribute to thrombotic diseases, such as venous thromboembolism (VTE) and ischemic stroke. Gamma prime (γ') fibrinogen is an isoform of fibrinogen that has anticoagulant properties. We applied 2-sample Mendelian randomization (MR) to estimate the causal effect of total circulating fibrinogen and its isoform, γ' fibrinogen, on risk of VTE and ischemic stroke subtypes using summary statistics from genome-wide association studies. Genetic instruments for γ' fibrinogen and total fibrinogen were selected, and the inverse-variance weighted MR approach was used to estimate causal effects in the main analysis, complemented by sensitivity analyses that are more robust to the inclusion of pleiotropic variants, including MR-Egger, weighted median MR, and weighted mode MR. The main inverse-variance weighted MR estimates based on a combination of 16 genetic instruments for γ' fibrinogen and 75 genetic instruments for total fibrinogen indicated a protective effect of higher γ' fibrinogen and higher total fibrinogen on VTE risk. There was also a protective effect of higher γ' fibrinogen levels on cardioembolic and large artery stroke risk. Effect estimates were consistent across sensitivity analyses. Our results provide evidence to support effects of genetically determined γ' fibrinogen on VTE and ischemic stroke risk. Further research is needed to explore mechanisms underlying these effects and their clinical applications.
引用
- Maners J, Gill D, Pankratz N, et al. A Mendelian randomization of γ' and total fibrinogen levels in relation to venous thromboembolism and ischemic stroke. Blood. 2020. PMID: 33367543. doi:10.1182/blood.2019004781
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。